BSEOthers31 Aug 2026 · 31 Aug 2026, 12:38 pm
Enclosed Annual Report for FY 2025-26 Scheduled on 30th September 2026.
Netripples Software Ltd · 542117
✦ AI SummaryResults
Netripples Software Ltd has submitted its Annual Report for FY 2025-26, with the 32nd Annual General Meeting scheduled on 30th September 2026. The company has maintained its zero-debt status, with reserves and surplus crossing ₹3 Crores. The report highlights the company's resilience in adapting to the AI-driven market and its focus on sustaining e-commerce operations in healthcare.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Netripples Software Ltd - 542117 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
ece0978e-1d3e-426b-b53f-38be9fa62db7.pdf
View document text
3 Netripples Software Limited
Registered Office : Goodlife Retreat , 1-2-36/2
Street No 4, Kakateeyanagar, Habsiguda,
Hyderabad — 500007, Telangana State
netripples Website: www.netripples.com
Email: info@netripples.com
Date: 31st August 2026
Ref: 33_ AGM/2025-26/BSE/REG34/543
The Manager- Listing Compliance
BSE Limited
P. J. Towers, Dalal Street
Mumbai — 400001
Subject: Submission of Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of
SEBI (LODR) Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please find enclosed herewith the Annual Report of the Company for the Financial Year 2025-
26 ending on 31.03.2026, along with the Notice convening the 32 Annual General Meeting
(“AGM") of the Company scheduled to be held on 30'h September 2026.
The Annual Report is also being made available on the Company's website at
www.netripples.com at Investorinfo Link.
You are requested to kindly take the same on record.
Thanking you,
For Netripples Software Limited
For netrippies
Software
Managing Director
Managing Director /Compliance Officer
Designation
netripples
NETRIPPLES SOFTWARE LIMITED
ANNUAL REPORT 2025-26
www.netripples.com
Page 1 of 12
netripples
NOTICE OF 32nd ANNUAL GENERAL MEETING
Notice is hereby given that the 32nd Annual General Meeting of the Members of Netripples
Software Limited will be held on Tuesday, 30th September 2026 at 11.00 A.M. at the Registered Office of the
Company at 2nd Floor, Goodlife Retreat Building, Municipal No. 1-2-86/2, Street No. 4, Kakateeyanagar,
Habsiguda, Hyderabad — 500007, Telangana, to transact the following business:
ORDINARY BUSINESS
1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year
ended March 31, 2026, including the Reports of the Board of Directors and Auditors thereon.
2.To Re-appoint Statutory Auditors M/s BGS and ASSOCIATES who retire in rotation with existing
remuneration as last year.
NOTES
1. A member entitled to attend and vote at the meeting is entitled to appoint a proxy to attend and vote ona
poll instead of himself/herself and the proxy need not be a member of the Company. 2. Trading of the
Company's shares is temporarily suspended. 3. The Register of Members and Share Transfer Books will
remain closed from 25th September 2025 to 30th September 2025 (both days inclusive). 4. Members are
requested to bring their copy of the Annual Report to the meeting.
Page 2 of 12
netripples
DIRECTORS’ REPORT
The Members of Netripples Software Limited
Your Directors have great pleasure in presenting their Annual Report together with the
Audited Financial Statements of the Company for the financial year ended 31st March,
2026.
1. Financial Highlights and Strength
1.1. During the year under review, the Company has maintained its stature as a Zero-Debt
Company, standing strong on a foundation of prudent fiscal discipline and resource
optimization.
1.2. The Company’s Reserves and Surplus have crossed %3 Crores, reflecting consistent
conservation of financial resources and a strong capacity to fund expansion and growth.
1.3. This resilient financial position provides a safeguard against market volatility and
supports the Company’s aspirations of sustaining and expanding its operations in
diversified business segments.
1.4. The Company and Company Directors have clean record in all Statutory bodies
including Income tax department with timely submissions and GST timely submissions and
no cases pending against any of the company directors nor the company itself.
2. Performance and Operations
2.1. The financial year witnessed significant challenges arising from the onslaught of
Artificial Intelligence (AI) products and services disrupting traditional business
models. Nevertheless, the Company has shown sustained business continuity by
adapting to this evolving environment.
2.2. One of the hallmarks of the Company's operational strategy has been the
preservation of cordial and long-term client relationships, which has ensured
recurring business and goodwill.
2.3. The Company continues to focus on balancing traditional revenue streams with
innovative explorations into new technology-enabled service areas.
3. Major Developments During the Year
Page 3 of 12
netripples
3.1. Exploration of New Business Opportunities — The Company has actively engaged
in evaluating emerging opportunities across technology-driven verticals.
3.2. Expansion of Network Reach — Strengthening alliances and expanding operational
presence across broader geographies and platforms.
3.3. Sustaining E-Commerce in Healthcare — The Company is proud to have become
one of the first in the industry to establish itself as a healthcare packaged product
provider for the SME segment. Today, the Company sustains an active e-commerce
portfolio of more than 75 products, downloadable solutions, online services, and
maintenance offerings. This initiative represents not only a diversification of revenue
streams but also a pioneering achievement in making healthcare technology accessible and
affordable for small and medium enterprises.
4. Outlook for the Coming Year
4.1. The foremost strategic priority is the revocation of the temporary suspension in
trading by BSE.
4.2. Your Company has already taken corrective measures to ensure timely submission
of quarterly and annual results in the revised SEBI formats, thereby aligning fully
with evolving compliance standards.
4.3. The future focus remains on consolidating current strengths, leveraging AI
advancements, and sustaining the momentum of healthcare e-commerce
operations, ensuring scalability, product innovation, and customer retention.
5. Corporate Governance and Compliance
5.1. The Board reaffirms its commitment to the highest standards of transparency,
accountability, and integrity in governance.
5.2. The Company has meticulously complied with requirements under the Companies
Act, 20138, the rules made thereunder, SEBI (LODR) Regulations, and guidelines issued
by BSE.
5.3. Constructive cooperation with BSE listing and compliance teams has ensured the
timely rectification of disclosures and filings, thereby reinforcing the Company’s
compliance culture.
Page 4 of 12
netripples
5.4. The Board also recognizes the valuable oversight of statutory auditors and regulators,
which has strengthened internal controls and enhanced governance practices.
6. Secretarial Audit
6.1. Pursuant to the provisions of Section 204 of the Companies Act, 2013, and the Rules
made thereunder, the Company has appointed a qualified Practicing Company Secretary to
conduct the Secretarial Audit of the Company.
6.2. The Secretarial Audit Report for the financial year ended 31st March, 2026, is
submitted in Exchange and available publicly.
6.3. There has been no adverse observations in the Secretarial Audit Report, however the
Board, and necessary corrective have noted the suggestions if any, measures are being
undertaken to ensure continuous improvement in compliance practices.
7. Acknowledgements
Your Directors wish to place on record their sincere appreciation to:
7.1. The Board of Directors — for their wisdom, guidance, and stewardship in navigating
the Company through a transformative year.
7.2. Auditors — for their valuable insights, independent opinion, and contribution to
financial transparency.
7.3. Employees — for their dedication, innovation, and resilience, which form the bedrock
of the Company’s progress.
7.4. Registrars, Depositories, and Statutory Bodies — for their professional support
and cooperation.
7.5. GST and Regulatory Authorities — for their constructive engagement and timely
guidance.
7.6. BSE Compliance and Listing Teams — for their constant support, corrections, and
guidance in enabling the Company to align with changing SEBI reporting formats.
7.7. Shareholders, Stakeholders, and Clients — whose trust, confidence, and long-term
partnerships remain the most valu
[Showing first 8,000 characters — download PDF for full document]